Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Erik Wendlandt

Low Serum miR-19a Expression as a Novel Poor Prognostic Indicator in Multiple Myeloma

International Journal of Cancer

Cancer Research

English

Related publications

Prognostic Value of CD56 Expression in Multiple Myeloma

Research in Oncology

English

TAZ Expression as a Prognostic Indicator in Colorectal Cancer

Multidisciplinary

English

Serum miR-26a as a Diagnostic and Prognostic Biomarker in Cholangiocarcinoma

English

Low Expression of Aldo–keto Reductase 1B10 Is a Novel Independent Prognostic Indicator for Nasopharyngeal Carcinoma

Cell and Bioscience

Molecular Biology

English

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and in Vivo Evidence

Clinical Cancer Research

Cancer Research

English

Serum Bone Sialoprotein as a Marker of Tumour Burden and Neoplastic Bone Involvement and as a Prognostic Factor in Multiple Myeloma

British Journal of Cancer

Cancer Research

English

Evaluation of Serum Β 2-Microglobulin as a Prognostic Indicator in Myelomatosis

British Journal of Cancer

Cancer Research

English

High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma

Cancer Gene Therapy

Cancer Research

Molecular Medicine

Molecular Biology

English

MicroRNA-19a Acts as a Prognostic Marker and Promotes Prostate Cancer Progression via Inhibiting VPS37A Expression

English